tree allergen
Allergenexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2012 (NCT01675791)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, desensitized
Tumor antigens immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tree allergen
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04878354 | Phase 3 | Apr 7, 2021 | ALK-Abello, S.A., Evangelisches Krankenhaus Düsseldorf, Parexel |
| NCT01675791 | Phase 2 | Aug 1, 2012 | ALK-Abello, S.A. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ALK-Abello, S.A. | For profit | 2 | 2 | 2 | 2012 |
| Evangelisches Krankenhaus Düsseldorf | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Parexel | For profit | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1